Blood Analyzers in Minnesota

DiaSorin Inc. is a global leader in laboratory diagnostics, specializing in immunodiagnostics and molecular diagnostics platforms. The company develops and manufactures diagnostic assays and analyzers for infectious diseases, immunological disorders, and other clinical applications. Core product lines include the LIAISON® automated immunoassay analyzer platform, Simplexa® molecular diagnostic kits for detection of viral pathogens (COVID-19, Flu A/B, RSV, HSV, CMV), and QuantiFERON® TB Gold Plus for tuberculosis detection. DiaSorin also offers the LIAISON® MeMed BV® for rapid bacterial-viral differentiation and LIAISON® BRAHMS PCT® for infection triage. The company operates the Luminex division, providing xMAP® multiplex assay technology platforms (xMAP INTELLIFLEX®) for biomedical research, clinical diagnostics, and drug discovery applications, including custom assay design and development services. Products address hospital laboratories, clinical diagnostic centers, and research institutions. The company maintains CLIA-waived status for certain molecular tests and holds FDA clearances and international regulatory approvals (CE marking). Manufacturing and distribution capabilities support North American and global markets.

R&D Systems is a leading provider of high-quality reagents and tools for life science research, established in 1976 in Minneapolis, Minnesota. As a key brand under Bio-Techne, the company specializes in products for basic, translational, and clinical research across cancer, immunology, and neuroscience. R&D Systems offers a comprehensive catalog including recombinant proteins, validated antibodies, ELISA kits, and specialized reagents for stem cell research and cell signaling. The company pioneered commercial release of the first recombinant cytokine, TGF-beta 1, in 1985. Operating a GMP-grade manufacturing facility in Saint Paul, MN, with global subsidiaries in the UK, Germany, France, and China, R&D Systems supports researchers in academic, biotech, and pharmaceutical sectors with over 500,000 products. The company provides application-specific validated antibodies, immunoassay kits, custom reagent development, and advanced analytical instruments for quantitative protein analysis and biomarker detection.

Radiometer Medical APS is a global acute care diagnostics company with over 70 years of industry experience. The company manufactures and integrates blood gas analyzers, point-of-care testing syringes, point-of-care IT solutions, and associated laboratory services. Operating across 59 countries with 3,780+ employees, Radiometer's portfolio addresses critical diagnostic workflows in hospitals and acute care settings. The company reports testing approximately 300,000 samples daily with its products, impacting approximately 4 million patients annually. Radiometer's core offerings include automated blood gas testing systems, integrated IT platforms for regulatory compliance and data management, and consumable supplies for acute care diagnostics. The company serves hospital networks, emergency departments, and intensive care units seeking standardized, automated diagnostic workflows. Radiometer operates as part of Danaher Corporation and maintains a customer portal using Microsoft Azure AD authentication, indicating enterprise-level software and data security infrastructure. The company's mission emphasizes streamlining diagnostic workflows to enable clinicians to focus on patient care in critical settings.